查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599521

穿戴式人工肾臟市场：按阶段、透析类型和最终用户 - 2025-2030 年全球预测

Wearable Artificial Kidney Market by Disease Stage (Acute Renal Disease, End-Stage Renal Disease), Dialysis Type (Hemodialysis, Peritoneal Dialysis), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年穿戴式人工肾臟市场价值为1.8019亿美元，预计2024年将达到2.1308亿美元，复合年增长率为18.74%，到2030年将达到5.9978亿美元。

穿戴式人工肾臟 (WAK) 是一项医疗创新，旨在为慢性肾臟病(CKD) 患者提供传统临床环境以外的肾臟替代治疗。该治疗装置旨在提高生活质量，提供连续透析治疗，与传统透析方法相比具有更大的机动性和灵活性。由于老化、糖尿病和高血压等因素，全球 CKD 盛行率不断增加，因此对 WAK 的需求源自于此。除了生命维持之外，WAK 还有可能减少与传统透析相关的併发症，例如感染风险和心血管问题。主要的最终使用场景包括居家医疗、门诊诊所以及偏远和服务不足的地区，提供了巨大的市场范围。公共和私人医疗保健支出的增加、小型化和生物相容性技术的进步是推动市场兴趣的关键成长要素。新的商机在于个人化治疗、与远端医疗服务整合以及与保险公司合作让 WAK 更容易获得。然而，其局限性包括高昂的研发成本、监管挑战以及需要大规模临床试验来确定安全性和有效性。进一步的挑战包括高昂的实施成本以及与现有医疗保健基础设施的复杂整合。研究创新应着重于延长电池寿命、小型化和提高生物相容性。生物材料和过滤效率的研究是突破技术界限的一个有前景的领域。此外，探索人工智慧主导的监测系统，为个人化患者照护提供预测分析，可以提供竞争优势。市场的本质是动态和竞争的，需要采取多学科方法来解决临床、技术和商业性障碍。公司应专注于与高科技公司和临床组织的合作，以优化产品开发并扩大其市场足迹，同时解决创新和监管合规问题。

主要市场统计
基准年[2023] 18019万美元
预测年份 [2024] 21308万美元
预测年份 [2030] 5.9978 亿美元
复合年增长率（%） 18.74%

市场动态：揭示快速发展的可穿戴人工肾臟市场的关键市场洞察

穿戴式人工肾臟市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 糖尿病和高血压的盛行率增加
    • 由于捐赠者短缺而限制移植
    • 人们对各种肾衰竭疾病和不健康生活方式的认识不断提高
  • 市场限制因素
    • 透析产品严格监管政策
  • 市场机会
    • 人工肾臟的技术进展
    • 提高患者选择门诊透析的意识
  • 市场挑战
    • 使用人工肾臟的併发症风险

波特五力：驾驭穿戴式人工肾臟市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对穿戴式人工肾臟市场的影响

外部宏观环境因素在塑造穿戴式人工肾臟市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解穿戴式人工肾臟市场的竞争状况

对穿戴式人工肾臟市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵穿戴式人工肾臟市场供应商绩效评估

FPNV 定位矩阵是评估穿戴式人工肾臟市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了穿戴式人工肾臟市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，可穿戴人工肾臟市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 糖尿病和高血压的增加
      • 由于缺乏捐赠者，移植受到限制
      • 人们对各种肾衰竭疾病和不健康生活方式的认识不断提高
    • 抑制因素
      • 透析产品严格监管政策
    • 机会
      • 人工肾臟的技术进步
      • 提高患者选择门诊透析的意识
    • 任务
      • 与使用人工肾臟相关的併发症的风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依疾病阶段分類的穿戴式人工肾臟市场

  • 急性肾臟病
  • 末期肾病

第七章穿戴式人工肾臟市场（依透析类型）

  • 血液透析机
  • 腹膜透析

第八章可穿戴人工肾臟市场：依最终用户分类

  • 门诊手术中心
  • 透析中心
  • 医院

第九章 北美及南美穿戴式人工肾臟市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太可穿戴人工肾臟市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲穿戴式人工肾臟市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • ANSELL LTD
  • Asahi Kasei Medical Co., Ltd.
  • AWAK Technologies
  • B. Braun
  • Baxter International Inc.
  • Blood Purification Technologies Inc.
  • Cardinal Health, Inc.
  • Dynarex Corporation
  • GE Healthcare
  • Glove Corporation Bhd
  • Hartalega Holdings
  • Hitachi Medical Corporation
  • KAWASUMI LABORATORIES, INC
  • Koninklijke Philips NV
  • Nanodialysis BV
  • Semperit AG Holding
  • Siemens AG
  • Triomed AB
Product Code: MRR-221461476D86

The Wearable Artificial Kidney Market was valued at USD 180.19 million in 2023, expected to reach USD 213.08 million in 2024, and is projected to grow at a CAGR of 18.74%, to USD 599.78 million by 2030.

The Wearable Artificial Kidney (WAK) is a transformative healthcare innovation designed to provide renal replacement therapy for patients with chronic kidney disease (CKD) outside the traditional clinical settings. This device aims to offer continuous dialysis treatment, enhancing quality of life through greater mobility and flexibility compared to conventional dialysis methods. The necessity of WAKs stems from the growing prevalence of CKD globally, driven by factors such as aging populations, diabetes, and hypertension. Its applications extend beyond life support, potentially reducing complications associated with traditional dialysis, such as infection risks and cardiovascular issues. Key end-use scenarios include home care, outpatient clinics, and remote or underserved areas, providing a significant market scope. The rising public and private healthcare expenditures and advancements in miniaturization and biocompatibility technologies are critical growth factors, helping drive market interest. Emerging opportunities lie in the personalization of treatments, integration with telehealth services, and partnerships with insurance providers to make WAK more accessible. However, limitations include high R&D costs, regulatory challenges, and the need for substantial clinical trials to establish safety and efficacy. Moreover, the high costs of implementation and the complexity of integrating with existing healthcare infrastructure pose challenges. Research innovation should focus on enhancing battery life, reducing size, and improving biocompatibility. Studies on biomaterials and filtration efficiencies are promising areas for pushing technological boundaries. Additionally, exploring AI-driven monitoring systems to provide predictive analytics for personalized patient care could offer competitive advantages. The market nature is dynamic and highly competitive, with an interdisciplinary approach needed to address clinical, technological, and commercial hurdles. Companies should emphasize collaborative ventures with tech firms and clinical entities to optimize product development and expand their market footprint, addressing both technological innovations and regulatory compliance simultaneously.

KEY MARKET STATISTICS
Base Year [2023] USD 180.19 million
Estimated Year [2024] USD 213.08 million
Forecast Year [2030] USD 599.78 million
CAGR (%) 18.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wearable Artificial Kidney Market

The Wearable Artificial Kidney Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of diabetes and hypertension
    • Low presence of donor, leading to limited transplantation
    • Rising awareness about various renal failure diseases, unhealthy lifestyles
  • Market Restraints
    • Stringent regulatory policies for dialysis products
  • Market Opportunities
    • Technological advancement in artificial kidney
    • Increase awareness among patients to opt for ambulatory dialysis
  • Market Challenges
    • Risk of complications of using artificial kidney

Porter's Five Forces: A Strategic Tool for Navigating the Wearable Artificial Kidney Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wearable Artificial Kidney Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wearable Artificial Kidney Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wearable Artificial Kidney Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wearable Artificial Kidney Market

A detailed market share analysis in the Wearable Artificial Kidney Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wearable Artificial Kidney Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wearable Artificial Kidney Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wearable Artificial Kidney Market

A strategic analysis of the Wearable Artificial Kidney Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wearable Artificial Kidney Market, highlighting leading vendors and their innovative profiles. These include ANSELL LTD, Asahi Kasei Medical Co., Ltd., AWAK Technologies, B. Braun, Baxter International Inc., Blood Purification Technologies Inc., Cardinal Health, Inc., Dynarex Corporation, GE Healthcare, Glove Corporation Bhd, Hartalega Holdings, Hitachi Medical Corporation, KAWASUMI LABORATORIES, INC, Koninklijke Philips N.V., Nanodialysis B.V., Semperit AG Holding, Siemens AG, and Triomed AB.

Market Segmentation & Coverage

This research report categorizes the Wearable Artificial Kidney Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Stage, market is studied across Acute Renal Disease and End-Stage Renal Disease.
  • Based on Dialysis Type, market is studied across Hemodialysis and Peritoneal Dialysis.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Dialysis Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of diabetes and hypertension
      • 5.1.1.2. Low presence of donor, leading to limited transplantation
      • 5.1.1.3. Rising awareness about various renal failure diseases, unhealthy lifestyles
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory policies for dialysis products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in artificial kidney
      • 5.1.3.2. Increase awareness among patients to opt for ambulatory dialysis
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of complications of using artificial kidney
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Wearable Artificial Kidney Market, by Disease Stage

  • 6.1. Introduction
  • 6.2. Acute Renal Disease
  • 6.3. End-Stage Renal Disease

7. Wearable Artificial Kidney Market, by Dialysis Type

  • 7.1. Introduction
  • 7.2. Hemodialysis
  • 7.3. Peritoneal Dialysis

8. Wearable Artificial Kidney Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Dialysis Centers
  • 8.4. Hospitals

9. Americas Wearable Artificial Kidney Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Wearable Artificial Kidney Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Wearable Artificial Kidney Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ANSELL LTD
  • 2. Asahi Kasei Medical Co., Ltd.
  • 3. AWAK Technologies
  • 4. B. Braun
  • 5. Baxter International Inc.
  • 6. Blood Purification Technologies Inc.
  • 7. Cardinal Health, Inc.
  • 8. Dynarex Corporation
  • 9. GE Healthcare
  • 10. Glove Corporation Bhd
  • 11. Hartalega Holdings
  • 12. Hitachi Medical Corporation
  • 13. KAWASUMI LABORATORIES, INC
  • 14. Koninklijke Philips N.V.
  • 15. Nanodialysis B.V.
  • 16. Semperit AG Holding
  • 17. Siemens AG
  • 18. Triomed AB

LIST OF FIGURES

  • FIGURE 1. WEARABLE ARTIFICIAL KIDNEY MARKET RESEARCH PROCESS
  • FIGURE 2. WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WEARABLE ARTIFICIAL KIDNEY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WEARABLE ARTIFICIAL KIDNEY MARKET DYNAMICS
  • TABLE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ACUTE RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-STAGE RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2023